Page last updated: 2024-11-03

praziquantel and Carcinoma, Hepatocellular

praziquantel has been researched along with Carcinoma, Hepatocellular in 2 studies

azinox: Russian drug

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"He had been previously diagnosed with chronic hepatitis B."1.48Hepatic Paragonimiasis Mimicking Hepatocellular Carcinoma. ( Fu, YY; Jia, QB; Lin, YX; Xiong, XZ, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, YX1
Jia, QB1
Fu, YY1
Xiong, XZ1
Thamavit, W1
Moore, MA1
Ruchirawat, S1
Ito, N1

Other Studies

2 other studies available for praziquantel and Carcinoma, Hepatocellular

ArticleYear
Hepatic Paragonimiasis Mimicking Hepatocellular Carcinoma.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2018, Volume: 22, Issue:3

    Topics: Adult; Animals; Anthelmintics; Carcinoma, Hepatocellular; Diagnosis, Differential; Hepatectomy; Hepa

2018
Lack of modulation effects of praziquantel on DMN-induced lesion development in the Syrian hamster liver.
    Cancer letters, 1992, Jan-31, Volume: 61, Issue:3

    Topics: Animals; Body Weight; Carcinoma, Hepatocellular; Cricetinae; Dimethylnitrosamine; Drug Interactions;

1992